The Truth About Alcohol: Risks, Benefits, and Everything In-Between
FoundMyFitnessKey Moments
Alcohol's effects on health are complex: no safe amount for cancer risk, but moderate intake may reduce cardiovascular disease and diabetes risk. Exercise and smart choices can mitigate harm when drinking.
Key Insights
One standard drink in the U.S. contains 14 grams of alcohol, but definitions vary globally. Factors like genetic variations, food intake, and age influence alcohol metabolism rate.
Alcohol is metabolized into toxic acetaldehyde, causing oxidative stress and inflammation, with an estimated 50% of alcohol use disorder susceptibility linked to genetics.
Alcohol disrupts nutrient absorption, causes leaky gut, and alters the gut microbiome, leading to inflammation and potentially impacting mental health and alcohol cravings.
Light to moderate alcohol consumption is associated with decreased brain volume but may reduce dementia risk in non-APOE4 carriers. APOE4 carriers should generally abstain.
Alcohol significantly impacts sleep by reducing sleep onset latency while disrupting REM sleep and increasing awakenings in the latter half of the night, especially at higher doses.
There is no safe level of alcohol for cancer risk; even light drinking increases the risk of certain cancers. However, moderate intake may have some protective effects on cardiovascular disease and type 2 diabetes, particularly in men without comorbidities.
Alcohol impairs male and female reproductive health, affecting sperm and egg quality, hormone levels, and increasing miscarriage risk. Both parents' alcohol consumption before conception can epigenetically impact offspring health.
Exercise can mitigate some negative effects of alcohol on the brain and reduce cravings by activating reward pathways and increasing beneficial hormones like FGF21.
DEFINING ALCOHOL CONSUMPTION AND METABOLISM
A standard U.S. drink is 14 grams of alcohol, varying from a 12-ounce beer to a 1.5-ounce shot of spirits. Drinking categories range from light (up to 3 drinks/week) to heavy (more than 7 for women, 14 for men). Alcohol is primarily metabolized in the liver by alcohol dehydrogenase (ADH) into toxic acetaldehyde, then by aldehyde dehydrogenase (ALDH) into acetate. Genetic variations in ADH and ALDH, food consumption, and age influence metabolism rates, impacting blood alcohol concentration and individual tolerance.
GENETIC AND ENVIRONMENTAL INFLUENCES ON ALCOHOL METABOLISM AND DISORDER
Genetic differences profoundly affect alcohol metabolism; for instance, ALDH2 and ADH1B variants common in East Asian populations cause rapid acetaldehyde accumulation, leading to flushing and nausea, thus reducing alcohol consumption. Approximately half of an individual's susceptibility to alcohol use disorder (AUD) is genetic, impacting dopamine responses in the brain's reward circuitry. Environmental factors and family history also play significant roles, influencing dopamine responses even to the expectation of drinking, suggesting a complex interplay between genes and environment in AUD development.
ALCOHOL'S IMPACT ON GASTROINTESTINAL HEALTH AND NUTRIENT ABSORPTION
Alcohol is calorie-dense but nutritionally devoid, providing 'empty calories' that displace nutrient-rich foods. It directly impairs nutrient absorption by causing structural changes to the intestinal lining (leaky gut), disrupting the microbiome, and inhibiting enzymatic digestion. This can lead to deficiencies in essential micronutrients like zinc, magnesium, and various B, C, D, E, and K vitamins. Even moderate alcohol consumption can promote some intestinal barrier dysfunction, though chronic heavy drinking significantly exacerbates these issues, increasing systemic inflammation.
THE GUT-BRAIN AXIS: ALCOHOL, MICROBIOME, AND ADDICTION SUSCEPTIBILITY
Alcohol profoundly influences the bidirectional communication between the gut and brain. It causes leaky gut, allowing bacterial toxins like lipopolysaccharide (LPS) to enter the bloodstream, triggering systemic and neuroinflammation. This inflammation can further compromise the gut barrier, creating a vicious cycle. Alcohol also disrupts the gut microbiome balance, reducing beneficial bacteria and altering neurotransmitter production (e.g., GABA, serotonin, dopamine) in the gut. Some research suggests that microbiome composition may increase susceptibility to AUD, with LPS injections in mice promoting increased alcohol consumption for months. Probiotics, prebiotics, and lifestyle changes like fiber and omega-3 intake may help restore gut health.
METHODOLOGICAL BIASES IN ALCOHOL RESEARCH: THE SICK QUITTER AND HEALTHY USER EFFECTS
Observational studies on alcohol and health often suffer from biases like the 'sick quitter effect,' where former heavy drinkers, who quit due to health issues, are misclassified as non-drinkers, artificially elevating health risks in the abstainer group. The 'healthy user effect' describes how healthier individuals are more likely to self-select into moderate drinking categories, confounding results. These biases can make moderate drinking appear protective when, in reality, it's often other healthy lifestyle factors prevalent among moderate drinkers that drive observed benefits. Accounting for these confounders often negates or significantly reduces purported protective effects of alcohol.
ALCOHOL'S NEUROCHEMICAL EFFECTS AND SHORT-TERM IMPACT ON THE BRAIN
Alcohol crosses the blood-brain barrier, activating the reward system by increasing dopamine in the ventral striatum and nucleus accumbens, leading to feelings of pleasure and reinforcement. Initially, it also increases serotonin and activates the ventral striatum, contributing to euphoria and calmness. Alcohol reduces anxiety by enhancing GABA's inhibitory effects and decreasing excitatory glutamate. However, these effects are transient; continued drinking depletes serotonin, and the brain adapts by downregulating GABA and upregulating glutamate receptors, leading to increased anxiety (hangxiety) and reduced overall brain activity during withdrawal.
ALCOHOL'S LONG-TERM EFFECTS ON BRAIN STRUCTURE AND COGNITION
Even moderate alcohol consumption (1-2 U.S. standard drinks daily) is linked to reduced overall brain volume, affecting both gray and white matter crucial for information processing and connectivity. Heavy consumption, as seen in AUD, leads to significant neuronal loss in regions governing emotions, memory, and navigation. Mechanisms of brain damage include thiamine deficiency, which impairs nerve function and blood-brain barrier integrity, potentially leading to iron overload. Acetaldehyde toxicity and chronic neuroinflammation, mediated by microglial and astrocytic activation, also contribute to neuronal loss and brain volume reduction.
ALCOHOL, DEMENTIA RISK, AND GENETIC PREDISPOSITION (APOE4)
Light to moderate alcohol consumption (up to 2-3 drinks/day) is associated with a reduced risk of cognitive impairment and dementia in middle to late adulthood, with some studies showing up to a 22-30% lower risk compared to abstainers. However, this protective effect significantly diminishes or reverses beyond 2-3 drinks per day. A critical factor is the APOE4 allele, a genetic risk factor for Alzheimer's disease. APOE4 carriers do not appear to experience the protective effects of moderate drinking; any alcohol consumption is associated with a greater risk of cognitive decline in these individuals, making zero drinks the safest choice.
MECHANISMS OF ALCOHOL'S PROTECTIVE EFFECTS ON COGNITIVE HEALTH
The potential protective effects of moderate alcohol on cognitive health are multifaceted. Alcohol may improve brain glucose tolerance by enhancing insulin-sensitive glucose transporters. It can also enhance cardiovascular health by raising HDL cholesterol, reducing blood coagulation, and improving blood flow to the brain, all crucial for preventing cognitive decline. Interestingly, low doses of alcohol might acutely improve glymphatic system activity, the brain's waste clearance system, which is most active during sleep, although this effect is impaired at higher doses. Resveratrol in red wine is often cited, but its concentration is too low in typical servings to have significant pharmacological effects.
ALCOHOL'S DOSE-DEPENDENT IMPACT ON SLEEP ARCHITECTURE
Alcohol consumed near bedtime consistently reduces sleep onset latency but disrupts sleep quality and architecture. It increases slow-wave (deep) sleep in the first half of the night, especially at moderate to high doses (3+ drinks), but significantly suppresses rapid eye movement (REM) sleep, which is crucial for memory and emotional regulation. This REM suppression, particularly in the first half of the night, is a notable effect across all alcohol doses. Alcohol also increases awakenings in the second half of the night, leading to less consistent sleep. Even afternoon alcohol consumption can negatively affect sleep quality, and individuals with sleep apnea should avoid alcohol before bed, as it worsens airway obstruction.
MITIGATING ALCOHOL'S NEGATIVE EFFECTS ON SLEEP AND HANGOVERS
To minimize sleep disruption, stop drinking at least 3-4 hours before bed and consume a substantial meal beforehand. Hydration and electrolyte replenishment (e.g., magnesium glycinate) may help, as alcohol is a diuretic and depletes electrolytes. Avoid combining melatonin with alcohol due to increased sedation. For hangovers, primary drivers are acetaldehyde toxicity, oxidative stress, and inflammation, not just dehydration. Congeners in darker spirits worsen symptoms. While no definitive cure exists, speculative remedies include fruits (pear, sweet lime, coconut water) to enhance alcohol metabolism, zinc and B3 for enzymatic function, and supplements like N-acetylcysteine and liposomal glutathione to boost detoxification. Avoiding NSAIDs and acetaminophen with alcohol is crucial due to potential liver toxicity.
ALCOHOL, LONGEVITY, AND DISEASE-SPECIFIC MORTALITY
Harmful alcohol use is a leading cause of premature death and disability worldwide. While some studies once suggested a U-shaped relationship with cardiovascular disease, robust analyses accounting for biases show no increase in life expectancy from alcohol. The lowest risk for all-cause mortality is observed with zero drinks, though up to 4 drinks per week may not significantly decrease life expectancy compared to abstainers. Moderate daily drinking in 'blue zones' (longevity hotspots) is often with meals and red wine, but their longevity is likely despite, not because of, alcohol, possibly due to unique genetics (e.g., FOXO3A gene) and other healthy lifestyle factors.
THE LINEAR RELATIONSHIP BETWEEN ALCOHOL AND CANCER RISK
Alcohol is a Group 1 carcinogen, with a dose-response relationship between consumption and increased risk for oropharyngeal, laryngeal, esophageal, liver, colon, rectal, and breast cancers. Even very light drinking (less than half a standard drink/day) increases breast cancer risk by about 4%. Moderate drinking (1-3 drinks/day) can significantly elevate risks (e.g., 12-123% increases for various cancers). Heavy drinking (3+ drinks/day) drastically raises risks (e.g., 300-400% for esophageal cancer). The risk of cancer due to alcohol is cumulative, without a safe threshold, making avoidance the best strategy for cancer prevention. Combining alcohol and tobacco dramatically increases cancer risk, up to 30 times for certain cancers.
ALCOHOL AND CANCER MECHANISMS: TOXICITY, INFLAMMATION, AND NUTRIENT DEPLETION
Alcohol contributes to cancer through multiple mechanisms. Acetaldehyde, a byproduct of alcohol metabolism, directly damages DNA and impairs DNA repair, leading to mutations. Ethanol-induced oxidative stress, particularly via CYP2E1 enzyme activity, generates reactive oxygen species that also harm DNA. Chronic alcohol consumption promotes inflammation by recruiting immune cells that release pro-inflammatory cytokines, further contributing to oxidative stress and DNA damage. Alcohol disrupts immune function (e.g., natural killer cells) and alters hormone levels (e.g., increased estrogen, relevant for breast cancer). Gut dysbiosis, nutrient deficiencies (vitamins A, B, C, D, folate, selenium, zinc, magnesium), and carcinogenic contaminants in alcoholic beverages also play roles.
ALCOHOL'S COMPLEX EFFECTS ON CARDIOVASCULAR HEALTH
Formerly, moderate alcohol was believed to be cardioprotective. However, studies rigorously accounting for the 'sick quitter effect' suggest the lowest cardiovascular disease (CVD) risk is below one standard drink per day or around 7 drinks per week. Beyond this, CVD risk increases linearly for stroke, heart failure, and hypertension. While moderate intake might slightly lower myocardial infarction risk, this is outweighed by increased risks for other CVDs and overall mortality. Industry-funded research has often overstated cardioprotective effects. For women, younger adults, and individuals with multiple comorbidities, no amount of alcohol has been shown to reduce CVD risk; in fact, even moderate intake may increase it. Heavy alcohol consumption causes microvascular remodeling, inflammation, endothelial dysfunction, and can lead to alcoholic cardiomyopathy.
ALCOHOL AND METABOLIC HEALTH: GLUCOSE, INSULIN, AND VISCERAL FAT
The relationship between alcohol and type 2 diabetes is U-shaped: moderate consumption (around 1.5 drinks/day) is associated with reduced diabetes risk, particularly in women, possibly due to improved insulin sensitivity and anti-inflammatory effects. However, this benefit reverses at higher consumption levels (3.5-4+ drinks/day). While alcohol acutely lowers blood glucose, consuming it solely for this purpose is misguided. Hazardous drinking is strongly linked to increased visceral fat, a hormonally active fat associated with cancer, CVD, and metabolic syndrome. Beer and spirits, in particular, are linked to greater visceral fat, while red wine is associated with less. Alcohol's empty calories, reduced fat oxidation, and increased appetite contribute to weight gain and visceral fat accumulation.
ALCOHOL'S IMPACT ON REPRODUCTIVE HEALTH AND FERTILITY
Alcohol disrupts the hypothalamic-pituitary-gonadal (HPG) axis, affecting hormone levels critical for fertility. Acute alcohol increases estrogen and decreases testosterone and progesterone, while chronic exposure leads to broader reproductive dysfunction. In women, alcohol is associated with irregular cycles, ovulation absence, increased miscarriage risk, and reduced pregnancy rates; even light drinking (less than 1 drink/day) lowers pregnancy chances by 11%. Studies show dose-dependent negative effects on egg and embryo quality. For men, light-to-moderate drinking (up to 7 drinks/week) may not impair sperm quality and even lower erectile dysfunction risk, but higher intake reduces semen volume, testosterone, and follicle-stimulating hormone. For couples trying to conceive, both partners should consider abstaining from alcohol for at least 3 months, as paternal alcohol consumption also epigenetically impacts offspring health.
ALCOHOL AND SEX HORMONES IN MEN: TESTOSTERONE
The effect of alcohol on male testosterone is dose-dependent. Low-to-moderate intake (e.g., 1-2 drinks) may slightly elevate testosterone by increasing liver detoxification enzymes, which convert androstenedione to testosterone. However, chronic heavy alcohol consumption consistently reduces testosterone levels by stimulating the HPA axis, leading to increased cortisol. Chronically high cortisol blunts testosterone production and secretion from the testes. Therefore, while minimal alcohol might not significantly impact testosterone, excessive drinking is detrimental to male sex hormone balance.
EPIGENETIC EFFECTS OF PRE-CONCEPTION ALCOHOL EXPOSURE
Beyond direct impacts during pregnancy, both maternal and paternal alcohol consumption before conception can epigenetically alter offspring health. Rodent studies show pre-conception binge drinking, by either parent, leads to smaller offspring body weight, impaired glucose tolerance, and reduced behavioral and pubertal development. Paternal alcohol intake has been linked to deficits in skull, facial, and organ growth, as well as impaired brain development, mimicking features of fetal alcohol spectrum disorders. The sperm epigenome is highly sensitive to environmental exposure, influencing offspring phenotypes. Abstaining from alcohol for at least 3 months before trying to conceive is recommended for both parents to minimize these long-term epigenetic risks.
ALCOHOL TYPE AND HEALTH OUTCOMES: THE RED WINE DEBATE
Red wine is often perceived as less harmful or even beneficial, partly due to polyphenols like resveratrol, but its concentrations are too low to exert significant effects. While some studies suggest red wine may be associated with less visceral fat, lower inflammation, and higher HDL compared to beer or spirits, and might offer a non-significantly lower risk for certain CVDs, these are associations, not causative benefits. Critically, red wine, like all alcohol, still linearly increases cancer risk. Some individuals experience headaches from red wine, possibly due to quercetin 3-glucuronide inhibiting ALDH2, leading to acetaldehyde accumulation. Choosing red wine should be viewed as a 'damage control' option rather than a path to health benefits.
ALCOHOL'S INTERPLAY WITH EXERCISE PERFORMANCE AND RECOVERY
Alcohol negatively affects exercise. It acutely reduces endurance performance but may not significantly impact strength. More importantly, alcohol hinders exercise recovery and adaptations. Doses above 0.5 g/kg body weight (around 5 drinks) impair rehydration. While it doesn't impede muscle glycogen restoration if consumed with carbohydrates, alcohol blunts muscle protein synthesis for up to 24 hours, even with adequate protein intake, thereby reducing potential gains. High doses promote a catabolic state and increase cortisol. Abstaining from alcohol during injury recovery is advisable. However, moderate alcohol consumption (1-2 drinks/day) doesn't negate cardiorespiratory fitness improvements from high-intensity interval training.
EXERCISE AS A TREATMENT FOR ALCOHOL USE DISORDER AND COGNITIVE PROTECTION
Exercise can counteract alcohol cravings and mitigate some brain damage from chronic use. It activates brain reward circuits, reducing the desire for alcohol, similar to its role in treating depression and anxiety. Meta-analyses show exercise interventions reduce drinking volume in individuals with AUD. Physiologically, exercise releases beta-endorphins and dopamine, which can substitute for alcohol's rewarding effects. Moreover, endurance exercise significantly increases fibroblast growth factor 21 (FGF21), a hormone that crosses the blood-brain barrier and can decrease alcohol consumption preference across species. Regular exercise may also protect white matter integrity in heavy drinkers, suggesting a beneficial interaction for brain health.
PRACTICAL DAMAGE CONTROL STRATEGIES FOR ALCOHOL CONSUMPTION
For those who choose to drink, the lowest-risk level for disease reduction is 1-2 drinks per week, primarily due to cancer risk. Binge drinking should always be avoided. To minimize adverse effects: time your last drink 4+ hours before sleep, eat a substantial meal with fruit before or during drinking, and ensure hydration with electrolytes and water. Magnesium glycinate and micronutrient replenishment may help. Speculative supplements like N-acetylcysteine, liposomal glutathione, and sulforaphane may aid detoxification. Avoid NSAIDs or acetaminophen with alcohol due to potential toxicity. Tracking sleep metrics with wearable devices can help individuals assess alcohol's impact on their health. Finally, maintaining an overall physically active lifestyle, especially regular exercise, significantly lessens all-cause mortality and cancer mortality risk associated with drinking, offering some protection even with occasional alcohol consumption.
Mentioned in This Episode
●Supplements
●Products
●Software & Apps
●Organizations
●Studies Cited
●Concepts
Alcohol Damage Control: Dos and Don'ts
Practical takeaways from this episode
Do This
Avoid This
Alcohol Consumption Categories (CDC Definitions)
Data extracted from this episode
| Category | Women (drinks/week) | Men (drinks/week) | Notes |
|---|---|---|---|
| Infrequent Drinkers | 1-11 per year | 1-11 per year | Consumed in the past year |
| Light Drinkers | <=3 | <=3 | At least 12 drinks in past year, average 3 or fewer per week |
| Moderate Drinkers | >3 to <7 | >3 to <14 | Average weekly consumption |
| Heavy Drinkers | >7 | >14 | Average weekly consumption |
| Low-Risk Drinking (NIAAA) | <=3 per day, <=7 per week | <=4 per day, <=14 per week | Recognizes total weekly and drinking pattern |
| Heavy Episodic Drinking (WHO) | 4+ (US), 6+ (Intl) per occasion | 5+ (US), 6+ (Intl) per occasion | 60g+ alcohol on 1+ occasion in last 30 days |
| Binge Drinking | 4+ (within 2 hrs) | 5+ (within 2 hrs) | Enough alcohol for 0.08% BAC, in <=2 hours |
Impact of Alcohol Consumption on Life Expectancy (by age 40)
Data extracted from this episode
| Drinks per Week | Reduction in Life Expectancy |
|---|---|
| <= 4 | No significant reduction compared to abstaining |
| ~8 | ~6 months |
| 15 | 1-2 years |
| 26 | 4-5 years |
Lifetime Cancer Risk Increase Due to Alcohol (Relative Risk)
Data extracted from this episode
| Cancer Type | Light Drinking (Relative Risk) | Moderate Drinking (Relative Risk) | Heavy Drinking (Relative Risk) |
|---|---|---|---|
| Breast Cancer (Women - Baseline 1 in 8) | ~4% | 12-123% (Up to 1 in 4) | Drastic Increase |
| Colorectal Cancer | ~9% | 12-123% (Men: Up to 1 in 10, Women: Up to 1 in 11) | Drastic Increase |
| Oral & Pharyngeal Cancer | 13-17% | 12-123% (Men: Up to 1 in 27, Women: Up to 1 in 63) | 300-400% |
| Esophageal Cancer | 26-44% | 12-123% (Men: Up to 1 in 92, Women: Up to 1 in 316) | 300-400% |
| Laryngeal Cancer | No significant elevation | 12-123% | 300-400% |
| Liver Cancer | No significant elevation | 12-123% (Men: Up to 1 in 36, Women: Up to 1 in 88) | Drastic Increase |
| Malignant Melanoma | 26-44% | N/A | N/A |
| Lung & Stomach Cancers | No significant elevation | N/A | 15-21% |
Common Questions
In the United States, one standard drink is 14 grams of alcohol (e.g., 12oz beer, 5oz wine, 1.5oz distilled spirits). Drinking categories range from infrequent (1-11 drinks/year) to heavy (women >7 drinks/week, men >14 drinks/week), with low-risk drinking defined as no more than 3/day (women) or 4/day (men), and no more than 7/week (women) or 14/week (men). Binge drinking is 4+ drinks for women and 5+ for men on a single occasion.
Topics
Mentioned in this video
A platform where users can upload genetic data to run a free genetic report and determine their APOE status.
A supplement used as an anti-hangover remedy, proposed to counteract alcohol's effects on Gaba receptors in the brain. Rodent studies suggest it reduces intoxication and withdrawal signs, and voluntary alcohol consumption, but strong human evidence is lacking.
Categorizes 'low-risk drinking' as having no more than three drinks on any single day and no more than seven drinks in a week for women, and no more than four drinks on any single day and no more than 14 drinks per week for men.
An enzyme primarily in the liver (and some in the stomach) that metabolizes ethanol into acetaldehyde as the first step in alcohol breakdown.
An enzyme that oxidizes acetaldehyde into acetate. Genetic variations in ALDH2 can lead to acetaldehyde accumulation and adverse reactions to alcohol.
A gut bacteria species that produces the neurotransmitter Gaba.
Dietary supplements that may improve gut microbiome composition, gut barrier integrity, and reduce inflammation, potentially aiding in treating alcohol use disorders or related conditions.
Substances that may improve gut microbiome composition, gut barrier integrity, and reduce inflammation, potentially aiding in treating alcohol use disorders or related conditions.
An essential vitamin for nerve function and brain health; alcohol consumption can lead to deficiency by impairing absorption and inhibiting its utilization, contributing to brain damage and potentially iron toxicity.
Medications like ibuprofen that are not advisable for preventing or treating hangovers, as they may slow alcohol metabolism and potentially worsen symptoms. Should be avoided with alcohol.
A genetic variation of the APOE gene known to increase the risk of Alzheimer's disease and dementia, especially for carriers who consume alcohol. Zero drinks are recommended for those with this allele.
A supplement intended to boost glutathione levels, potentially helping mitigate alcohol's damaging effects and aid liver detoxification. While theoretically supported, human clinical evidence is sparse and largely speculative.
A genetically engineered probiotic bacteria that produces acetaldehyde dehydrogenase (ALDH) in the gut, marketed to reduce hangover symptoms by metabolizing acetaldehyde. There is no published randomized control trial evidence to support its efficacy.
A derivative of the polyphenol quercetin, present in red wine, hypothesized to cause red wine headaches by inhibiting ALDH2, leading to higher acetaldehyde levels. This hypothesis awaits human testing.
A minor pathway enzyme for alcohol metabolism, which becomes more active at high blood alcohol concentrations and increases with chronic alcohol consumption, playing a role in alcohol metabolism for individuals with alcohol use disorder.
A gut bacteria species that can produce serotonin.
An excitatory neurotransmitter whose levels are reduced by alcohol, contributing to calming effects. Regular consumption can lead to upregulation of glutamate receptors during withdrawal, increasing brain excitability and anxiety.
A precursor to glutathione, suggested to help mitigate alcohol's effects by boosting glutathione and potentially reacting with acetaldehyde. Human studies show mixed results, with some benefits noted for women in reducing specific hangover symptoms.
An analysis of almost 2,000 participants from the UK Biobank study where drinking more red wine was associated with less visceral fat, lower inflammation, and higher HDL, while beer and spirits were linked to opposite effects.
A bacterial endotoxin that can cross the intestinal barrier when compromised by alcohol, entering the bloodstream and inducing a highly toxic inflammatory response linked to type 2 diabetes, heart disease, and liver disease. Increased LPS also promotes further alcohol consumption.
A gut bacteria species that can produce dopamine.
A genetic test kit provider that can be used to determine APOE4 status.
More from FoundMyFitness
View all 92 summaries
2 minWatch my episode with Dr. Charles Brenner
115 minHow To Boost NAD Levels To Fight Inflammation, Improve Recovery, and Slow Aging
92 minDr. Rhonda Patrick: Maximizing Healthspan with Exercise, Sauna, & Cold Exposure
131 minWhy Vigorous Exercise Is 4–10x More Effective Than Moderate (New Evidence)
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free